Navigation Links
BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
Date:10/16/2007

- Nexus CGH Gets Scientists 'Back to the Bench'-

EL SEGUNDO, Calif., Oct. 16 /PRNewswire/ -- BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of NEXUS CGH version 2, the first commercial software tool that provides easy, fast and powerful platform independent and cross-platform analysis of multiple array based DNA copy number data sets, simultaneously.

NEXUS CGH easily supports large-scale array experiments involving thousands of samples from any platform, including high-density multi-million probe SNP as well as two-color CGH arrays. Its user-friendly interface, allows the researcher to quickly identify potential regions of significant copy number changes in various biological categories and extract a gene list for the smallest region of overlap in the sample set.

"Using NEXUS CGH, my lab has been able to quickly and confidently process large amounts of high-density array CGH data obtained from FFPE tumor samples to identify important chromosomal regions," said Dr. Jeff Gregg head of Molecular Pathology at UC Davis. "NEXUS CGH has allowed us to move from raw data into exploring CNV's and associated genes in a matter of few hours whereas this process took months to complete with other commercial or academic packages."

Dr. Anjene Addington, Child Psychiatry Branch, NIMH, NIH said, "With Nexus CGH, we are able to quickly and easily identify key regions of interest and jump straight to relevant statistical tests and bioinformatics tools, making the whole process more efficient."

Nexus CGH version 2 is the only commercial package offering unique features such as statistical significance test of aberration frequencies, automatic identification of regions of significant statistical difference between sample groups, clustering samples based on genomic profile, and much more.

"We have received an overwhelmingly positive reception to Nexus CGH from leading research institutions including UCSF, Johns Hopkins, UCLA, NIH, The Norwegian Radium Hospital, UCD, Duke, City of Hope, Harvard, and Dundee University," said Dr. Soheil Shams, CEO, BioDiscovery, Inc. "Nexus CGH version 2 enables scientists to convert mountains of copy number data into actionable knowledge in a matter of minutes."

About BioDiscovery

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or http://www.biodiscovery.com.


'/>"/>
SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics
6. Sun Pharma to launch chiral version of omeprazole soon
7. Slimmer’s Delight: Potato Version 2, on a platte
8. Friends of Earth Protest water Diversion Project ,Garrison-II.
9. Latest Version of Echocardiography Provides Improved Pictures of the Heart
10. First Generic Version of Lexapro permitted by US
11. Sun Pharma Allots Shares Upon Fccbs Conversion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... its services to provide one resource, from start to finish, for Life Safety ... Safety Statement of Condition surveys requested by the Joint Commission, and fire stopping ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... advisory organization, is pleased to welcome new Partner Firm Austin & Co., Inc. ... consultative approach to insurance, employee benefits, HR consulting, benefits technology, and beyond. ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... How to ... · Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the ... that human error will ever be totally eliminated, many human performance problems can be ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- Grow ... its Advisory Board. Joining the Grow Healthy Advisory Board team ... them embody the mission of our organization and bring talent, expertise ... them as we continue to expand our footprint as the leader ...
(Date:5/24/2016)... ... ... Backed by decades of experience, Metroloji Okulu works with ... suited solution to meet regulatory requirements. Their professional staff also performs on-site installations ... Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical data loggers ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 ... , la première endoprothèse à double ... à l,intervention portant sur les membres inférieurs ... OrbusNeich, entreprise mondiale spécialisée dans la ... la vie, a élargi son portefeuille pour ...
(Date:5/23/2016)... , May 23, 2016 ... Handling Equipment Market by Product (Wheelchair, Scooters, Medical ... (Bariatric Care, Critical Care, Wound), Accessories (Lifting, Transfer) ... to 2021", published by MarketsandMarkets, the patient handling ... Billion by 2021 at a CAGR of 10.5% ...
(Date:5/23/2016)... 23, 2016 According to ... Development, Growth and Demand Forecast to 2022 - ... by Application (Drug Discovery and Development, Proteomics, Clinical ... Life Science and Biotechnology, Academic and Research Institute, ... the global mass spectrometry market was ...
Breaking Medicine Technology: